Evaluation of fungal extracts to determine immunomodulatory properties

Journal of Investigational Allergology and Clinical Immunology

Volumn 23, Issue 4, 2013, Pages 226-233

  Ranta, K ^a   Nieminen, K ^a   Saariaho, T ^a   Kortekangas Savolainen, O ^a   Kumpula, E K ^a   Kosonen, J ^a   Pasanen, A L ^b   Savolainen, Johannes ^a,c  

^a UNIVERSITY OF TURKU   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Candida albicans; Mannan; Mold; Mushroom; TH1 cell; TH2 cell; Yeast

Indexed keywords

ACREMONIUM FURCATUM EXTRACT; AGARICUS BISPORUS EXTRACT; ALTERNARIA ALTERNATA EXTRACT; ASPERGILLUS UMBROSUS EXTRACT; ASPERGILLUS VERSICOLOR EXTRACT; AUREOBASIDIUM PULLULANS EXTRACT; BETA ACTIN; CANDIDA ALBICANS EXTRACT; CHAETOMIUM GLOBOSUM EXTRACT; FUNGAL EXTRACT; GAMMA INTERFERON; MESSENGER RNA; PAXILLUS INVOLUTUS EXTRACT; PHIALOPHORA REPENS EXTRACT; STACHYBOTRYS CHARTARUM EXTRACT; ULOCLADIUM BOTRYTIS EXTRACT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; FEMALE; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MALE; MOULD; MUSHROOM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; YEAST;

AGARICALES; CELLS, CULTURED; CETRIMONIUM COMPOUNDS; COMPLEX MIXTURES; DETERGENTS; FUNGAL POLYSACCHARIDES; FUNGI; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MANNANS; MANNOSE; TH1-TH2 BALANCE; YEASTS;

EID: 84879445560     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kilpeläinen M, Terho EO, Helenius H, Koskenvuo M. Childhood farm environment and asthma and sensitization in young adulthood. Allergy. 2002;57(12):1130-5.
2. Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrländer C, Heederik D, Piarroux R, von Mutius E, GABRIELA Transregio 22 Study Group. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701-9.
3. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol. 2002;3(8):715-20.
4. Romagnani S. Understanding the role of Th1/Th2 cells in infection. Trends Microbiol. 1996;4:470-3.
5. Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy. 2001;56(6):498-505.
6. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, Khattignavong AP, Lindblad R, Li H, Coffman R, Seyfert V, Eiden JJ, Broide D. Immune Tolerance Network Group. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med. 2006;5:1445-55.
7. Murphy JW, Bistoni F, Deepe GS, Blackstock RA, Buchanan K, Ashman RB, Romani L, Mencacci A, Cenci E, Fè d'Ostiani C, Del Sero G, Calich VL, Kashino SS. Type 1 and type 2 cytokines: from basic science to fungal infections. Med Mycol. 1998;36:109-18.
8. Huffnagle GB, Deepe GS. Innate and adaptive determinants of host susceptibility to medically important fungi. Curr Opin Microbiol. 2003;6:344-50.
9. Mencacci A, Torosantucci A, Spaccapelo R, Romani L, Bistoni F, Cassone A. A mannoprotein constituent of C. albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect Immun. 1994;62:5353-60.
10. Savolainen J, Kosonen J, Lintu P, Viander M, Pène J, Kalimo K, Terho EO, Bousquet J. Candida albicans mannan-and protein-induced humoral, cellular and cytokine responses in atopic dermatitis patients. Clin Exp Allergy. 1999;29:824-31.
11. Pietrella D, Cherniak R, Strappini C, Perito S, Mosci P, Bistoni F, Vecchiarelli A. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun. 2001;69:2808-14.
12. Suzuki Y, Adachi Y, Ohno N, Yadomae T. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-3)-beta-glucans from fungi. Biol Pharm Bull. 2001;24:811-9.
13. Kodama N, Harada N, Nanba H. A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol. 2002;90:357-60.
14. Murata Y, Shimamura T, Tagami T, Takatsuki F, Hamuro J. The skewing to Th1 induced by lentinan is directed through the distinctive cytokine production by macrophages with elevated intracellular glutathione content. Int Immunopharmacol. 2002;2:673-89.
15. Jeurink P, Noguera C, Savelkoul H, Wichers H. Immunomodulatory capacity of fungal proteins on the cytokine production of human peripheral blood mononuclear cells. Int Immunopharmacol. 2008;8:1124-33.
16. Leeming JP, Notman FH. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol. 1987;25:2017-9.
17. Koivikko A, Kalimo K, Nieminen E, Savolainen J, Viljanen M, Viander M. Allergenic cross-reactivity of yeasts. Allergy. 1988;43:192-200.
18. Savolainen J, Kalimo K, Einarsson R, Koivikko A, Viander M, Terho EO. In-house reference (IHR) preparation of C. albicans allergen extract. A standardized extraction procedure. Allergy. 1998;53:359-66.
19. Kaukonen K, Savolainen J, Viander M, Terho EO. Characterization of Aspergillus umbrosus carbohydrate antigens by biotinylated lectins and IgG response to mannan/mannoprotein antigens in patients with farmer's lung. Clin Exp Allergy. 1993;23:21-7.
20. Pasanen AL, Yli-Pietilä K, Pasanen P, Kalliokoski P, Tarhanen J. Ergosterol content in various fungal species and biocontaminated building materials. Appl Environ Microbiol. 1999;65:138-42.
21. Raunio P, Kärkkäinen M, Virtanen T, Rautiainen J, Pasanen AL. Preliminary description of antigenic components characteristic of Stachybotrys chartarum. Environ Res. 2001;85:246-55.
22. Nakajima T, Ballou CE. Characterization of the carbohydrate fragments obtained from Saccharomyces cerevisiae mannan by alkaline degradation. J Biol Chem. 1974;249:7679-84.
23. Laaksonen K, Junikka M, Lahesmaa R, Terho EO, Savolainen J. In vitro allergen-induced mRNA expression of signaling lymphocytic activation molecule by PBMC of patients with allergic rhinitis is increased during specific pollen immunotherapy. J Allergy Clin Immunol. 2003;112:1171-7.
24. Bohle B, Jahn-Schmid B, Maurer D, Kraft D, Ebner C. Oligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitro. Eur J Immunol. 1999;29:2344-53.
25. Savolainen J, Nieminen K, Waris M, Mäkelä MJ, Terho EO. Tuberculin-primed PBMC fail to produce TH2-type cytokines. Allergy. 2000;55:895-6.
26. Tulic MK, Wale JL, Holt PG, Sly PD. Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol. 2000;22:604-12.
27. Broide DH, Stachnick G, Castaneda D, Nayar J, Miller M, Cho J, Rodriquez M, Roman M, Raz E. Immunostimulatory DNA mediates inhibition of eosinophilic inflammation and airway hyperreactivity independent of natural killer cells in vivo. J Allergy Clin Immunol. 2001;108:759-63.
28. Gerhold K, Blümchen K, Bock A, Seib C, Stock P, Kallinich T, Löhning M, Wahn U, Hamelmann E. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol. 2002;110:110-6.
29. Puggioni F, Durham SR, Francis JN. Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses. Allergy. 2005;60:678-84.
30. Heintel T, Breinig F, Schmitt MJ, Meyerhans A. Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans. FEMS Immunol Med Microbiol. 2003;39:279-86.
31. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol. 2001;166:4620-6.
32. Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, Matsumoto T, Ohno N, Tamura H, Shibata K, Akashi S, Miyake K, Sugawara S, Takada H. Saccharomyces cerevisiae-and C. albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14-and Toll-like receptor 4-dependent manner. Microbiol Immunol. 2002;46:503-12.
33. Jouault T, Ibata-Ombetta S, Takeuchi O, Trinel PA, Sacchetti P, Lefebvre P, Akira S, Poulain D. C. albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis. 2003;188:165-72.
34. Mansour MK, Levitz SM. Interactions of fungi with phagocytes. Curr Opin Microbiol. 2002;5:359-65.
35. Romani L, Bistoni F, Puccetti P. Fungi, dendritic cells and receptors: a host perspective of fungal virulence. Trends Microbiol. 2002;10:508-14.
36. Okemoto K, Kawasaki K, Hanada K, Miura M, Nishijima M. A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1. J Immunol. 2006;176(2):1203-8.
37. Jouault T, Fradin C, Trinel PA, Poulain D. Candida albicans-derived beta-1, 2-linked mannooligosaccharides induce desensitization of macrophages. Infect Immun. 2000;68:965-8.
38. Faille C, Wieruszeski JM, Lepage G, Michalski JC, Poulain D, Strecker G. 1H-NMR spectroscopy of manno-oligosaccharides of the beta-1, 2-linked series released from the phosphopeptidomannan of C. albicans VW-32 (serotype A). Biochem Biophys Res Commun. 1991;181:1251-8.
39. Kobayashi H, Shibata N, Osaka T, Miyagawa Y, Ohkubo Y, Suzuki S. Structural study of cell wall mannan of a C. albicans (serotype A) strain. Phytochemistry. 1992;31:1147-53.
40. Trinel PA, Lepage G, Jouault T, Strecker G, Poulain D. Definitive chemical evidence for the constitutive ability of Candida albicans serotype A strains to synthesize beta-1, 2 linked oligomannosides containing up to 14 mannose residues. FEBS Lett. 1997;416:203-6.
41. Fradin C, Jouault T, Mallet A, Mallet JM, Camus D, Sinaÿ P, Poulain D. Beta-1, 2-linked oligomannosides inhibit C. albicans binding to murine macrophage. J Leukoc Biol. 1996;60:81-7.
42. Jouault T, Lepage G, Bernigaud A, Trinel PA, Fradin C, Wieruszeski JM, Strecker G, Poulain D. Beta-1, 2-linked oligomannosides from C. albicans act as signals for tumor necrosis factor alpha production. Infect Immun. 1995;63:2378-81.